IT1251540B - Uso di un derivato gangliosidico. - Google Patents

Uso di un derivato gangliosidico.

Info

Publication number
IT1251540B
IT1251540B ITPD910101A ITPD910101A IT1251540B IT 1251540 B IT1251540 B IT 1251540B IT PD910101 A ITPD910101 A IT PD910101A IT PD910101 A ITPD910101 A IT PD910101A IT 1251540 B IT1251540 B IT 1251540B
Authority
IT
Italy
Prior art keywords
gangliosidic
derivative
ester
dysmetabolisms
antineuronotoxic
Prior art date
Application number
ITPD910101A
Other languages
English (en)
Inventor
Aurelio Romeo
Alberta Leon
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Priority to ITPD910101A priority Critical patent/IT1251540B/it
Publication of ITPD910101A0 publication Critical patent/ITPD910101A0/it
Priority to EP92109069A priority patent/EP0516132A1/en
Priority to JP4140410A priority patent/JPH05208916A/ja
Priority to KR1019920009464A priority patent/KR920021152A/ko
Priority to CA002070124A priority patent/CA2070124A1/en
Publication of ITPD910101A1 publication Critical patent/ITPD910101A1/it
Application granted granted Critical
Publication of IT1251540B publication Critical patent/IT1251540B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

La presente invenzione si riferisce ad un nuovo uso di un estere carbossilico del ganglioside GM1 in terapeutica. Tale estere possiede uno specifico e spiccato effetto antineuronotossico che si può sfruttare per contrastare i danni al sistema nervoso provocati dall'azione di amminoacidi eccitatori, come nel caso di ischemie, ipossie, traumi e compressioni, dismetabolismi, nell'epilessia, nelle malattie neurodegenerative croniche e nel dolore cronico.-
ITPD910101A 1991-05-31 1991-05-31 Uso di un derivato gangliosidico. IT1251540B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITPD910101A IT1251540B (it) 1991-05-31 1991-05-31 Uso di un derivato gangliosidico.
EP92109069A EP0516132A1 (en) 1991-05-31 1992-05-29 Anti-neuronotoxic activity and therapeutic applications of GM1 ganglioside methyl ester
JP4140410A JPH05208916A (ja) 1991-05-31 1992-06-01 Ｇｍ１ガングリオシドのメチルエステルの抗ニューロン毒活性およびその治療のための使用
KR1019920009464A KR920021152A (ko) 1991-05-31 1992-06-01 Gm_₁ 강글리오사이드의 메틸 에스테르의 항-신경독성 활성과 그의 치료학적 용도
CA002070124A CA2070124A1 (en) 1991-05-31 1992-06-01 Uses of a ganglioside derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD910101A IT1251540B (it) 1991-05-31 1991-05-31 Uso di un derivato gangliosidico.

Publications (3)

Publication Number Publication Date
ITPD910101A0 ITPD910101A0 (it) 1991-05-31
ITPD910101A1 ITPD910101A1 (it) 1992-12-01
IT1251540B true IT1251540B (it) 1995-05-17

Family

ID=11389596

Family Applications (1)

Application Number Title Priority Date Filing Date
ITPD910101A IT1251540B (it) 1991-05-31 1991-05-31 Uso di un derivato gangliosidico.

Country Status (5)

Country Link
EP (1) EP0516132A1 (it)
JP (1) JPH05208916A (it)
KR (1) KR920021152A (it)
CA (1) CA2070124A1 (it)
IT (1) IT1251540B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011094367A1 (en) 2010-01-26 2011-08-04 Evans Michael A Methods, devices, and agents for denervation
WO2020040615A1 (ko) * 2018-08-24 2020-02-27 연세대학교 산학협력단 강글리오사이드를 함유하는 근육 질환 예방 또는 치료용, 또는 근 기능 개선용 조성물
CN111407768A (zh) * 2020-05-15 2020-07-14 内蒙古自治区中医药研究所 一类组合物在神经损伤保护领域的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi

Also Published As

Publication number Publication date
ITPD910101A1 (it) 1992-12-01
CA2070124A1 (en) 1992-12-01
JPH05208916A (ja) 1993-08-20
EP0516132A1 (en) 1992-12-02
ITPD910101A0 (it) 1991-05-31
KR920021152A (ko) 1992-12-18

Similar Documents

Publication Publication Date Title
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
ATE338563T1 (de) Verfahren zur behandlung von patienten die unter multipler sklerose leiden mit konsensus- interferon
IT1261949B (it) Composizione terapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo.
ES2102196T3 (es) Periferializacion de celulas pluripotenciales hematopoyeticas.
NZ326754A (en) The use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene or salts thereof for the prophylaxis and treatment of sequelae of chronic reduced circulation in the brain in particular strokes and for neurodegenerative disorders
TR200002570T2 (tr) Glisin naklini önleyiciler
IT1261984B (it) Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
FR2695714B1 (fr) Installation de traitement cryogénique, notamment de distillation d'air.
EP0147777A3 (de) N-glycosylierte Carbonsäureamid-Derivate als Mittel bei der Bekämpfung von Erkrankungen des rheumatischen Formenkreises
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1251540B (it) Uso di un derivato gangliosidico.
NO932377L (no) Antivirale forbindelser
ATE297722T1 (de) Verwendung von gaba analoga wie gabapentin zur herstellung eines medikaments für die behandlung von entzündungserkrankungen
NO934159D0 (no) Nye heterosykliske karboksylsyrer
CA2141679A1 (en) New Derivatives of Neuraminic Acid
ITRM910327A0 (it) Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie.
EP0396081A3 (en) The use of phosphatidyl-carnitine for the preparation of pharmaceutical compositions having an activity in the therapy of human pathologies associated with neuronal damage
FR2725443B1 (fr) Preparation d'acides carboxyliques ou des esters correspondants par carbonylation en presence d'iridium
ATE317391T1 (de) 4-aminotetrahydrobenzisoxazole oder -isothiazole
IT1271623B (it) N-acilderivati di aminoalcoli con acidi monocarbossilici e bicarbossilici con attivita' neuroprotettiva nelle patologie neurologiche correlate ad eccitotossicita'
IT1261808B (it) Impiego di l-carnitina o acido l-carnitine e valproato nel trattamentodei disosrdini convulsivi
GR3015685T3 (en) 5-Aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders.
ES2066605T3 (es) Nuevas ureas y tioureas, su preparacion y su aplicacion en terapeutica.
DE59610798D1 (de) Antiseptikum fuer die augenschleimhaut enthaltend magnesiumperphthalat
TR199801021T2 (xx) Mide-ba��rsak bozukluklar�n�n �nlenmesi ve tedavisi i�in bizmut i�eren bile�imler.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960531